Jiarou Wang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled Trial.

Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled Trial.

Journal: Vascular health and risk management

Published: September 20, 2025

Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs/NF-κB signaling pathway.

Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs/NF-κB signaling pathway.

Journal: International immunopharmacology

Published: December 24, 2024

Taoren Honghua Decoction alleviates atherosclerosis by inducing autophagy and inhibiting the PI3K-AKT signaling pathway to regulate cholesterol efflux and inflammatory responses.

Taoren Honghua Decoction alleviates atherosclerosis by inducing autophagy and inhibiting the PI3K-AKT signaling pathway to regulate cholesterol efflux and inflammatory responses.

Journal: International immunopharmacology

Published: August 09, 2024

Tanshinone IIA alleviates atherosclerosis in LDLR-/- mice by regulating efferocytosis of macrophages.

Tanshinone IIA alleviates atherosclerosis in LDLR-/- mice by regulating efferocytosis of macrophages.

Journal: Frontiers in pharmacology

Published: June 06, 2023

Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy.

Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy.

Journal: Frontiers in pharmacology

Published: March 27, 2023

Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation.

Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation.

Journal: Frontiers in cardiovascular medicine

Published: November 29, 2022

Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice.

Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 09, 2022

Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease.

Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease.

Journal: Journal of translational medicine

Published: April 09, 2022

The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis.

The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis.

Journal: PloS one

Published: January 06, 2022

Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR-/- Mice.

Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR-/- Mice.

Journal: Frontiers in pharmacology

Published: December 03, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026